These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7737555)

  • 21. Effects of misoprostol on gastric acid and mucus secretion in man.
    Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of prostaglandin E2 in gastric and duodenal mucosa: possible role in the pathogenesis of peptic ulcer.
    Park SM; Yoo BC; Lee HR; Chung H; Lee YS
    Korean J Intern Med; 1992 Jan; 7(1):1-8. PubMed ID: 1477025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of acute ethanol ingestion on human gastric luminal prostaglandin E2, prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha.
    Bode C; Ganzhorn A; Brauner B; Bode JC
    Alcohol Alcohol; 1989; 24(1):35-42. PubMed ID: 2920071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
    Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
    Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa.
    Treiber G; Wex T; Link A; Vieth M; Laufer S; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Jan; 23(1):155-67. PubMed ID: 16393293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa.
    Larsen KR; Dajani EZ; Ives MM
    Dig Dis Sci; 1992 Jul; 37(7):1029-38. PubMed ID: 1319887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered release of eicosanoids by rat alveolar macrophages during granulomatous pulmonary inflammation.
    Shellito J; Sniezek M
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):289-96. PubMed ID: 2155633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette smoking reduces human gastric luminal prostaglandin E2.
    McCready DR; Clark L; Cohen MM
    Gut; 1985 Nov; 26(11):1192-6. PubMed ID: 3864718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A natural flavonoid, IdB 1027, increases gastric luminal release of prostaglandin E2 in healthy subjects.
    Mertz-Nielsen A; Munck LK; Bukhave K; Rask-Madsen J
    Ital J Gastroenterol; 1990 Oct; 22(5):288-90. PubMed ID: 2134327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 attenuation of sheep lung responses to endotoxin.
    Brigham KL; Serafin W; Zadoff A; Blair I; Meyrick B; Oates JA
    J Appl Physiol (1985); 1988 Jun; 64(6):2568-74. PubMed ID: 2841275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators.
    Eliakim R; Stalnikowicz R; Ackerman Z; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1994 Oct; 30(10):751-6. PubMed ID: 7960687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.
    Playford RJ; Batten JJ; Freeman TC; Beardshall K; Vesey DA; Fenn GC; Baron JH; Calam J
    Gut; 1991 Nov; 32(11):1396-400. PubMed ID: 1752476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
    Cole AT; Filipowicz B; Hyman-Taylor P; Hawkey CJ
    Aliment Pharmacol Ther; 1994 Oct; 8(5):521-6. PubMed ID: 7865644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of 3H-prostaglandin E2 binding sites in the rabbit gastric mucosa.
    Tomoi M; Matsuo M; Ono T; Shibayama F
    Prostaglandins; 1990 Feb; 39(2):113-22. PubMed ID: 2107564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and somatostatin-stimulated gastric intraluminal prostaglandin E2 in patients with gastric ulcer and with gastric adenocarcinoma.
    Materia A; Silecchia G; Genco A; Spaziani E; De Leo A; Pizzuto G; Basso N
    Digestion; 1990; 45(3):153-7. PubMed ID: 1973675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misoprostol: a prostaglandin E1 analogue.
    Garris RE; Kirkwood CF
    Clin Pharm; 1989 Sep; 8(9):627-44. PubMed ID: 2507215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.